Martin, S.S., et al., 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation, 2025.
Wurie HR, Cappuccio FP. Cardiovascular disease in low- and middle-income countries: an urgent priority. Ethn Health. 2012;17(6):543–50.
Article PubMed PubMed Central Google Scholar
Magnussen C, et al. Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality. N Engl J Med. 2023;389(14):1273–85.
Article CAS PubMed PubMed Central Google Scholar
Lanas F, Serón P, Lanas A. Coronary heart disease and risk factors in latin america. Glob Heart. 2013;8(4):341–8.
Hernández-Hernández R, et al. Hypertension in seven Latin American cities: the Cardiovascular Risk Factor Multiple Evaluation in Latin America (CARMELA) study. J Hypertens. 2010;28(1):24–34.
Ikemura, N., et al., International Variation in Health Status Benefits in Patients Undergoing Initial Invasive Versus Conservative Management for Chronic Coronary Disease: Insights From the ISCHEMIA Trial. Circulation: Cardiovascular Quality and Outcomes, 2024. 17(10): p. e010534.
Lanas F, et al. Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study. Circulation. 2007;115(9):1067–74.
Avezum A, et al. Secondary CV Prevention in South America in a Community Setting: The PURE Study. Glob Heart. 2017;12(4):305–13.
McEvoy JW, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45(38):3912–4018.
Vogel B, et al. The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. Lancet. 2021;397(10292):2385–438.
Rivera, M.A.M., C.M. Artucio, and G.M.M.d. Oliveira, How Can We Expand Knowledge to Improve Women’s Cardiovascular Health in Latin America? International Journal of Cardiovascular Sciences, 2024. 37: p. -.
Borrayo-Sánchez G, P.-B.A., Almonte C, et al. , Impact of heart disease on women in Latin America. Cardiovasc Metab Sci 2022. 33: p. s421–422.
Venditti, V., et al., Gender-Related Factors in Medication Adherence for Metabolic and Cardiovascular Health. Metabolites, 2023. 13(10).
Arnett DK, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e596–646.
PubMed PubMed Central Google Scholar
Khera R, et al. Performance of the Pooled Cohort Equations to Estimate Atherosclerotic Cardiovascular Disease Risk by Body Mass Index. JAMA Netw Open. 2020;3(10): e2023242.
Article PubMed PubMed Central Google Scholar
Khan SS, et al. Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association. Circulation. 2023;148(24):1982–2004.
Kelkar AA, et al. Long-Term Prognosis After Coronary Artery Calcium Scoring Among Low-Intermediate Risk Women and Men. Circ Cardiovasc Imaging. 2016;9(4): e003742.
Cho L, et al. Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020;75(20):2602–18.
Article PubMed PubMed Central Google Scholar
Maas A, et al. Cardiovascular health after menopause transition, pregnancy disorders, and other gynaecologic conditions: a consensus document from European cardiologists, gynaecologists, and endocrinologists. Eur Heart J. 2021;42(10):967–84.
Article CAS PubMed PubMed Central Google Scholar
Agarwala A, et al. The Use of Sex-Specific Factors in the Assessment of Women’s Cardiovascular Risk. Circulation. 2020;141(7):592–9.
Article PubMed PubMed Central Google Scholar
Kawai K, et al. Differences in Stable and Unstable Atherosclerotic Plaque. Arterioscler Thromb Vasc Biol. 2024;44(7):1474–84.
Article CAS PubMed Google Scholar
Golub IS, et al. Major Global Coronary Artery Calcium Guidelines. JACC Cardiovasc Imaging. 2023;16(1):98–117.
Benschop L, et al. Early Onset of Coronary Artery Calcification in Women With Previous Preeclampsia. Circ Cardiovasc Imaging. 2020;13(11): e010340.
Shaw LJ, et al. Sex differences in calcified plaque and long-term cardiovascular mortality: observations from the CAC Consortium. Eur Heart J. 2018;39(41):3727–35.
Article PubMed PubMed Central Google Scholar
Patel MR, et al. Low diagnostic yield of elective coronary angiography. N Engl J Med. 2010;362(10):886–95.
Article CAS PubMed PubMed Central Google Scholar
Kaski JC, et al. Reappraisal of Ischemic Heart Disease. Circulation. 2018;138(14):1463–80.
Gosselin G, et al. Effectiveness of Percutaneous Coronary Intervention in Patients With Silent Myocardial Ischemia (Post Hoc Analysis of the COURAGE Trial). Am J Cardiol. 2012;109(7):954–9.
Boden WE, et al. Myocardial ischaemic syndromes: a new nomenclature to harmonize evolving international clinical practice guidelines. Eur Heart J. 2024;45(36):3701–6.
Ford TJ, Berry C. Angina: contemporary diagnosis and management. Heart. 2020;106(5):387–98.
Article CAS PubMed Google Scholar
Maron DJ, et al. Initial Invasive or Conservative Strategy for Stable Coronary Disease. N Engl J Med. 2020;382(15):1395–407.
Article PubMed PubMed Central Google Scholar
Hadamitzky M, et al. Prognostic value of coronary computed tomography angiography during 5 years of follow-up in patients with suspected coronary artery disease. Eur Heart J. 2013;34(42):3277–85.
Peerwani G, et al. Predictors of Non-Obstructive Coronary Artery Disease in Patients Undergoing Elective Coronary Angiography. Glob Heart. 2023;18(1):26.
Article PubMed PubMed Central Google Scholar
Bairey Merz CN, et al. Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade. Circulation. 2017;135(11):1075–92.
Pacheco Claudio C, et al. Why names matter for women: MINOCA/INOCA (myocardial infarction/ischemia and no obstructive coronary artery disease). Clin Cardiol. 2018;41(2):185–93.
Article PubMed PubMed Central Google Scholar
Jespersen L, et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J. 2012;33(6):734–44.
Taqueti VR, et al. Excess Cardiovascular Risk in Women Relative to Men Referred for Coronary Angiography Is Associated With Severely Impaired Coronary Flow Reserve. Not Obstructive Disease Circulation. 2017;135(6):566–77.
Mileva N, et al. Prevalence of Coronary Microvascular Disease and Coronary Vasospasm in Patients With Nonobstructive Coronary Artery Disease: Systematic Review and Meta-Analysis. J Am Heart Assoc. 2022;11(7): e023207.
Article PubMed PubMed Central Google Scholar
Smilowitz NR, et al. Coronary Microvascular Disease in Contemporary Clinical Practice. Circ Cardiovasc Interv. 2023;16(6): e012568.
Comments (0)